Marie-Clémence Verdier

6PUBLICATIONS
14CO-AUTHORS
Molecular targetsClinical pharmacy and pharmacy practiceCancer therapy (excl. chemotherapy and radiation therapy)Sub-acute carePharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 22, 2026
Can pharmacokinetic/pharmacodynamic targets be achieved with voriconazole in the treatment of urinary tract infections caused by Candida spp. with reduced susceptibility to fluconazole?

|Mar 03, 2026
Managing High-Risk Drug Interactions With Nirmatrelvir/Ritonavir: Experience From a Dedicated Pharmacology Advice Service.

Youssef Libiad, Bénédicte Franck, Camille Tron

|Jun 28, 2025
Cefepime Concentration-Toxicity Relationship in Hematological Patients Treated With Continuous Infusion: A Prospective Study.

Sébastien Lalanne, Marie-Noëlle Osmont, Louise Triquet

|Dec 02, 2024
One Concentration Does Not Fit All: It Is Time to Personalize the Therapeutic Range of Infliximab in Crohn Disease.

Bénédicte Franck, Camille Tron, Marie-Clémence Verdier

|Mar 04, 2024
Transient Lactic Acidosis and Elevation of Transaminases after the Introduction of Remdesivir in a Patient with Acute Kidney Injury.

Elise André, Florian Lemaitre, Marie-Clémence Verdier

|May 28, 2022
A Robust and Fast/Multiplex Pharmacogenetics Assay to Simultaneously Analyze 17 Clinically Relevant Genetic Polymorphisms in CYP3A4, CYP3A5, CYP1A2, CYP2C9, CYP2C19, CYP2D6, ABCB1, and VKORC1 Genes.

Camille Tron, Régis Bouvet, Marie-Clémence Verdier

Pageof 1

Frequent Collaborators

5 joint publications

Florian Lemaitre

1 joint publications

Elise André

1 joint publications

Vincent Haufroid

1 joint publications

João Pinto Pereira